Diagnosis: Sebaceous carcinoma of the eyelid
A 62-year-old female presented with a yellowish nodule on the right lower eyelid, initially treated as a recurrent chalazion. Despite multiple interventions, the lesion persisted, prompting further evaluation, which ultimately led to the diagnosis of sebaceous carcinoma. This case highlights the importance of considering malignancy in atypical eyelid lesions.
A 62-year-old female presented with a yellowish nodule on the right lower eyelid, persisting for three months. The patient reported intermittent swelling and discomfort, initially diagnosed as a recurrent chalazion. On examination, the nodule was firm, non-tender, and exhibited a slight telangiectatic appearance.Location: Right lower eyelid.Size: Approximately 1.5 cm in diameter.Color: Yellowish with slight erythema.Consistency: Firm and non-tender.Associated findings: Mild eyelid swelling.
The lesion began three months prior, with no known triggers or significant associated symptoms. The patient had a history of multiple treatments for presumed chalazia, including warm compresses and intralesional corticosteroids, with no improvement. There was no significant past medical history, and family history was unremarkable for skin cancers. The patient denied any recent sun exposure or exposure to carcinogens.Onset: Lesion developed over three months.Treatments: Warm compresses and intralesional steroids.Past medical history: No significant history.Family history: No skin cancer.Social history: Non-smoker, minimal sun exposure.
Acute / First-Line ManagementWide local excision is the primary treatment for sebaceous carcinoma, aiming for clear margins (at least 4 mm). Mohs micrographic surgery is preferred when feasible, especially for eyelid lesions to minimize recurrence and preserve eyelid function.Consideration for postoperative radiation therapy may be warranted in cases with high-risk features (e.g., perineural invasion).Workup and Diagnostic ConfirmationHistopathological examination of the excised tissue is essential for diagnosis, revealing atypical sebocytes and basaloid cells.Imaging studies, such as MRI, may be indicated to assess for local invasion or metastasis if the tumor is aggressive.Long-Term ManagementRegular follow-up is crucial to monitor for recurrence, typically every 3-6 months for the first 2 years.Educate the patient on signs of recurrence and the importance of sun protection.
Chalazion: A common benign eyelid lesion characterized by a blocked meibomian gland; typically presents as a painless nodule and is responsive to conservative treatment.Basal Cell Carcinoma: The most common skin cancer, it may present as a pearly nodule or ulceration; histology shows nests of basaloid cells.Squamous Cell Carcinoma: Can appear as a crusted or ulcerative lesion on the eyelid; often associated with sun exposure; may exhibit keratinization.Keratoacanthoma: A rapidly growing, dome-shaped lesion that may mimic a chalazion; often resolves spontaneously but may require excision if persistent.Meibomian Gland Carcinoma: Malignant tumor arising from meibomian glands, presenting similarly to a chalazion but with a more aggressive course.Muir-Torre Syndrome: A rare genetic condition characterized by sebaceous tumors and internal malignancies; consider in patients with multiple sebaceous lesions.Dermatofibroma: A benign fibrous nodule that may resemble a chronic chalazion; typically firm and mobile.Inflammatory Lesions: Conditions such as blepharitis or other inflammatory processes can mimic eyelid tumors but usually have associated symptoms like itch or redness.
High-Yield PearlsAwareness: Always consider malignancy in persistent eyelid lesions that do not respond to conventional treatments.Diagnosis: Histopathological examination is key to confirming sebaceous carcinoma; look for atypical sebocytes.Management: Mohs micrographic surgery is the gold standard for excision of eyelid tumors to ensure clear margins and preserve eyelid function.Genetic Syndromes: Muir-Torre syndrome should be suspected in patients with multiple sebaceous tumors or associated internal malignancies.Follow-up: Regular monitoring is essential for detecting recurrence, particularly in high-risk patients.Consider any persistent eyelid nodule as a potential malignancy until proven otherwise.
Tags: sebaceous carcinoma, Muir-Torre